Integra LifeSciences Corporation
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Integra LifeSciences Corporation sits in the top decile of US sponsors by registered trial count (#336 of 15,742 sponsors by registered trial count).
Integra LifeSciences Corporation: 60 sponsored US clinical trials, 3 recruiting.
Integra LifeSciences Corporation sponsors 60 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 38 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetic Foot Ulcer, with 2 trials.
Top-decile sponsor footprint
Integra LifeSciences Corporation ranks in the top decile of sponsors by registered trial count (#336 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
38 of 57 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
60 total, page 2 of 2
Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus
NCT00941993
PleuraSeal Post Market Study (Europe)
NCT00704171
Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study
NCT02369497
Study to Evaluate Safety & Effectiveness of Spinal Sealant
NCT00444067
Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis
NCT00939471
Clinical Evaluation of the Ethmoid Sinus Spacer
NCT01054703
Study to Evaluate Safety & Effectiveness of Vascular Sealant System
NCT00439309
DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
NCT00387829
DuraSeal Sealant Post Market Study
NCT00704340
Study to Evaluate Safety and Effectiveness of Spinal Sealant
NCT00594035
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
Where Integra LifeSciences Corporation enrollment is open (later-stage tilt)
3 recruiting of 60 indexed (5% open); 38 completed (63%).
Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Diabetic Foot Ulcer (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Integra LifeSciences Corporation: open-pipeline peers nationwide
Peers matched on 60 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Integra LifeSciences Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 60 trials (± recruiting share)
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 60 trials · 22% recruiting
- Endo USA Inc., a Keenova Therapeutics Company · 61 trials · 0% recruiting
- NICHD Neonatal Research Network · 61 trials · 7% recruiting
- Clinical Nutrition Research Center, Illinois Institute of Technology · 59 trials · 7% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Avera McKennan Hospital & University Health Center · 5% recruiting · 20 trials
- HonorHealth Research Institute · 5% recruiting · 20 trials
- Lumenis Be · 5% recruiting · 20 trials
- Nathan Kline Institute for Psychiatric Research · 5% recruiting · 20 trials
Related
What to do with this Integra LifeSciences Corporation page
60 registered trials is a research-attention snapshot, not an endorsement of Integra LifeSciences Corporation or any single study.
- 3 of Integra LifeSciences Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diabetic Foot Ulcer is the condition Integra LifeSciences Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetic Foot Ulcer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Integra LifeSciences Corporation pipeline card: 60 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.